Sage Journals: Discover world-class research

Free access

Research article

First published 2016-2

High-Throughput Mass Spectrometric Analysis of Covalent Protein-Inhibitor Adducts for the Discovery of Irreversible Inhibitors

Iain D. G. Campuzano, Tisha San Miguel, Todd Rowe [...]

Journal of Biomolecular Screening

Retricted access

Research article

First published 1997-2

Vitamin E attenuates the effects of both reversible and irreversible inhibitors of high-affinity choline transport in vivo

Robert W. Stackman, Adam C. Bartolomeo, Thomas J. Walsh

Restorative Neurology and Neuroscience

Retricted access

Research article

First published 2016-12-6

Cholinesterase Inhibitor Therapy in Alzheimer’s Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates

Donald E. Moss, Ruth G. Perez, Haruo Kobayashi

Journal of Alzheimer’s Disease

Free access

Research article

First published 2020-5

Nonclinical Safety Assessment of Zanubrutinib: A Novel Irreversible BTK Inhibitor

Cuining Zhang, Baohong Tian

International Journal of Toxicology

Retricted access

Research article

First published 1994-06

A C 2 Symmetry-Based HIV Protease Inhibitor,A77003,Irreversibly Inhibits Infectivity of HIV-1 In Vitro

Seiji Kageyama, David T. Hoekzema, Yohko Murakawa [...]

AIDS Research and Human Retroviruses

Retricted access

Research article

First published 2022-8

Quantitative evaluation and pharmacokinetic characteristics of the irreversible BTK inhibitor zanubrutinib in mouse plasma using LC-MS/MS

Kai Cheng, Junsong Wei, Jianrong Kou [...]

European Journal of Mass Spectrometry

Free access

Abstract

First published 1981-6

Cytochemical localization of ornithine decarboxylase with rhodamine or biotin-labeled alpha-difluoromethylornithine. An example for the use of labeled irreversible enzyme inhibitors as cytochemical markers.

G M Gilad, V H Gilad

Journal of Histochemistry & Cytochemistry

Free access

Research article

First published 2008-4

Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors,Including the Epidermal Growth Factor Receptor

Alan P. Brown, Robert W. Dunstan, Cynthia L. Courtney [...]

Toxicologic Pathology

Free access

Research article

First published 1985-01

Effects of the Irreversible Ornithine Decarboxylase Inhibitor,α-Difluoromethylornithine,Aflatoxin B 1,and Choline Deficiency on Hepatocarcinogenesis

Dorrit Sondergaard, Francee Taylor, Paul M. Newberne

Toxicologic Pathology

Retricted access

Case report

First published 2015-3

Long Progression-free Survival with Afatinib in a Patient with EGFR-unknown Lung Adenocarcinoma after Erlotinib Failure: A Case Report

Maria Giuseppa Vitale, Sarah Scagliarini, Ferdinando Riccardi [...]

Tumori Journal

Search results